We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Consolidates Live-Cell Wound Care Regulation in Biologics Center
FDA Consolidates Live-Cell Wound Care Regulation in Biologics Center
August 16, 2013
The FDA is shifting responsibility for wound care products containing live cells from CDRH to the Center for Biologics Evaluation and Research, which already oversees all other live-cell products.